PFG Investments LLC Sells 607 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

PFG Investments LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,657 shares of the financial services provider’s stock after selling 607 shares during the quarter. PFG Investments LLC’s holdings in iShares Biotechnology ETF were worth $1,188,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Corient Private Wealth LLC grew its holdings in iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after buying an additional 841 shares in the last quarter. Mmbg Investment Advisors CO. grew its holdings in iShares Biotechnology ETF by 0.6% during the fourth quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock worth $10,671,000 after buying an additional 495 shares in the last quarter. Oppenheimer & Co. Inc. grew its holdings in iShares Biotechnology ETF by 7.6% during the first quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock worth $4,905,000 after buying an additional 2,532 shares in the last quarter. Chemistry Wealth Management LLC grew its holdings in iShares Biotechnology ETF by 20.6% during the first quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock worth $488,000 after buying an additional 609 shares in the last quarter. Finally, Future Financial Wealth Managment LLC bought a new stake in iShares Biotechnology ETF during the first quarter worth $27,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $144.53 on Tuesday. The stock’s fifty day simple moving average is $144.27 and its two-hundred day simple moving average is $138.08. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.17.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.